IS3505A7 - Endurröðunarkerfi til framsetningar undireininga kóleru-B með hjálp utanaðkomandi stýrihvata og/eða stjórnpepiða - Google Patents

Endurröðunarkerfi til framsetningar undireininga kóleru-B með hjálp utanaðkomandi stýrihvata og/eða stjórnpepiða

Info

Publication number
IS3505A7
IS3505A7 IS3505A IS3505A IS3505A7 IS 3505 A7 IS3505 A7 IS 3505A7 IS 3505 A IS3505 A IS 3505A IS 3505 A IS3505 A IS 3505A IS 3505 A7 IS3505 A7 IS 3505A7
Authority
IS
Iceland
Prior art keywords
cholera
diphtheria
help
ctb
external catalyst
Prior art date
Application number
IS3505A
Other languages
English (en)
Other versions
IS1804B (is
Inventor
Holmgren Jan
Sanches Castillo Joaquin
Original Assignee
Vitec Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitec Aktiebolag filed Critical Vitec Aktiebolag
Publication of IS3505A7 publication Critical patent/IS3505A7/is
Publication of IS1804B publication Critical patent/IS1804B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/55Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IS3505A 1988-09-16 1989-09-04 Endurröðunarkerfi til framsetningar undireininga kóleru-B með hjálp utanaðkomandi stýrihvata og/eðastjórnpepiða IS1804B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803291A SE462285B (sv) 1988-09-16 1988-09-16 Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer

Publications (2)

Publication Number Publication Date
IS3505A7 true IS3505A7 (is) 1990-03-17
IS1804B IS1804B (is) 2002-02-26

Family

ID=20373364

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3505A IS1804B (is) 1988-09-16 1989-09-04 Endurröðunarkerfi til framsetningar undireininga kóleru-B með hjálp utanaðkomandi stýrihvata og/eðastjórnpepiða

Country Status (13)

Country Link
EP (1) EP0368819B1 (is)
JP (1) JP2790333B2 (is)
AT (1) ATE161885T1 (is)
AU (1) AU633842B2 (is)
CA (1) CA1340577C (is)
DE (1) DE68928529T2 (is)
DK (1) DK175694B1 (is)
ES (1) ES2113342T3 (is)
FI (1) FI104496B (is)
GR (1) GR3025846T3 (is)
IS (1) IS1804B (is)
NO (1) NO301175B1 (is)
SE (1) SE462285B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03187383A (ja) * 1989-09-04 1991-08-15 Takeda Chem Ind Ltd 発現プラスミドおよびその用途
US5356797A (en) * 1991-11-15 1994-10-18 Board Of Regents, The University Of Texas Membrane expression of heterologous genes
WO1993010246A1 (en) * 1991-11-15 1993-05-27 Board Of Regents, The University Of Texas System Membrane expression of heterologous genes
US5932714A (en) * 1995-02-23 1999-08-03 Connaught Laboratories Limited Expression of gene products from genetically manipulated strains of Bordetella
US5998168A (en) * 1995-06-07 1999-12-07 Connaught Laboratories Limited Expression of gene products from genetically manipulated strains of bordetella
US6008329A (en) * 1998-03-06 1999-12-28 The United States Of America As Represented By The Secretary Of The Army Method for purifying cholera toxin
WO2007117339A2 (en) * 2006-01-11 2007-10-18 The United States Of America As Respresented By The Secretary Of The Navy Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli
DE102011111688A1 (de) * 2011-08-24 2013-02-28 Bioserv Analytik Und Medizinprodukte Gmbh Verfahren zur schnellen Isolation bzw. Aufreinigung von rekombinanten Proteinen mit einer (nicht toxischen) Choleratoxin-Domäne
CN109096403B (zh) * 2018-07-04 2020-06-30 浙江工商大学 一种用于蛋白质转导的蛋白质载体及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666837A (en) * 1982-05-24 1987-05-19 Smithkline-Rit DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
US4882278A (en) * 1983-04-29 1989-11-21 President And Fellows Of Harvard College Non-toxinogenic vibrio cholerae mutants
EP0251579A3 (en) * 1986-06-24 1989-03-22 Enterovax Research Pty. Ltd. Non-antibiotic marker system
JP2777894B2 (ja) * 1987-04-29 1998-07-23 プレジデント アンド フェロウズ オブ ハーバード カレッジ コレラワクチン

Also Published As

Publication number Publication date
DE68928529T2 (de) 1998-04-16
JPH0322997A (ja) 1991-01-31
FI104496B (fi) 2000-02-15
EP0368819B1 (en) 1998-01-07
JP2790333B2 (ja) 1998-08-27
SE8803291D0 (sv) 1988-09-16
ATE161885T1 (de) 1998-01-15
IS1804B (is) 2002-02-26
AU4134989A (en) 1990-04-05
CA1340577C (en) 1999-06-01
NO301175B1 (no) 1997-09-22
ES2113342T3 (es) 1998-05-01
EP0368819A1 (en) 1990-05-16
FI894368L (fi) 1990-03-17
NO893702D0 (no) 1989-09-15
DE68928529D1 (de) 1998-02-12
DK456989A (da) 1990-03-17
DK175694B1 (da) 2005-01-24
AU633842B2 (en) 1993-02-11
SE462285B (sv) 1990-05-28
DK456989D0 (da) 1989-09-15
FI894368A0 (fi) 1989-09-15
NO893702L (no) 1990-03-19
GR3025846T3 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
SE8107812L (sv) Rekombinerade dna-molekyler och forfaranden for framstellning av proteiner
DK221589D0 (da) Fremgangsmaade til at udtrykke ikke-gaerprotein i en gaervaert og transformeret gaervaert
AU573523B2 (en) Functional human urokinase proteins
EP0196864A3 (en) Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences
ATE44768T1 (de) Verfahren zur mikrobiologischen herstellung von menschlichem serum-albumin.
IL87255A0 (en) Dna constructs containing a kluyveromyces alphafactor leader sequence for directing secretion of heterologous polypeptides
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
IS1804B (is) Endurröðunarkerfi til framsetningar undireininga kóleru-B með hjálp utanaðkomandi stýrihvata og/eðastjórnpepiða
BG60255B2 (bg) Метод за получаване на пептиди
NO911557D0 (no) Fremgangsmaate for fremstilling av fremmedproteiner i streptomyceter.
BR9714133A (pt) ácido nucleico isolado, molécula do mesmo, sonda, vetor de expressão recombinante, célula, polipeptìdeo, proteìna de fusão formulação de vacina e processos para produzir um polipeptìdeo de h. pylori, para detctar a presença de um ácido nucleico de helicobacter em uma amostra, para tratar ou reduzir um risco de infecção por h. pylori em um indivìduo e para produzir uma formulação de vacina
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
NO173194C (no) Fremgangsmaate for fremstilling av proinsulin
DK0467839T3 (da) In-vitro-behandling af fusionsproteiner
EP0229712A3 (en) The production of human serum albumin in bacillus
NO883611L (no) Ekspresjonsplasmider som inneholder deo-promotere, og bakterielle verter som inneholder disse plasmidene.
JPS6486876A (en) Variant human lysozyme
ATE91717T1 (de) Verfahren zur herstellung von proteinen in loeslicher form.
SE8800981D0 (sv) A recombinant fusion protein, its use and a recombinant vector
IE881768L (en) Cell system for exression of recombinant protein